• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子动力学的监督学习(SuMD)作为一种有用的工具,可在纳秒时间尺度上描绘 GPCR-配体识别途径。

Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale.

机构信息

Molecular Modeling Section (MMS), Dipartimento di Scienze del Farmaco, Università di Padova , via Marzolo 5, 35131 Padova, Italy.

出版信息

J Chem Inf Model. 2014 Feb 24;54(2):372-6. doi: 10.1021/ci400766b. Epub 2014 Feb 3.

DOI:10.1021/ci400766b
PMID:24456045
Abstract

Supervised MD (SuMD) is a computational method that allows the exploration of ligand-receptor recognition pathway investigations in a nanosecond (ns) time scale. It consists of the incorporation of a tabu-like supervision algorithm on the ligand-receptor approaching distance into a classic molecular dynamics (MD) simulation technique. In addition to speeding up the acquisition of the ligand-receptor trajectory, this implementation facilitates the characterization of multiple binding events (such as meta-binding, allosteric, and orthosteric sites) by taking advantage of the all-atom MD simulations accuracy of a GPCR-ligand complex embedded into explicit lipid-water environment.

摘要

有监督 MD(SuMD)是一种计算方法,可在纳秒(ns)时间尺度内探索配体-受体识别途径的研究。它由在配体-受体接近距离上将类似于禁忌的监督算法纳入经典分子动力学(MD)模拟技术组成。除了加快配体-受体轨迹的获取外,这种实现还通过利用嵌入到明确定义的脂质-水环境中的 GPCR-配体复合物的全原子 MD 模拟的准确性,方便了对多个结合事件(如元结合、变构和正位结合)的特征描述。

相似文献

1
Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale.基于分子动力学的监督学习(SuMD)作为一种有用的工具,可在纳秒时间尺度上描绘 GPCR-配体识别途径。
J Chem Inf Model. 2014 Feb 24;54(2):372-6. doi: 10.1021/ci400766b. Epub 2014 Feb 3.
2
Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.将分子对接与膜分子动力学相结合,研究 GPCR-配体识别:以人 A₂A 腺苷受体为关键研究对象。
J Chem Inf Model. 2014 Jan 27;54(1):169-83. doi: 10.1021/ci400532b. Epub 2014 Jan 8.
3
Supervised Molecular Dynamics (SuMD) Approaches in Drug Design.药物设计中的监督式分子动力学(SuMD)方法。
Methods Mol Biol. 2018;1824:287-298. doi: 10.1007/978-1-4939-8630-9_17.
4
Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations.重新审视钠离子对人 A 腺苷受体上腺苷结合的变构调节:来自监督分子动力学 (SuMD)模拟的见解。
Molecules. 2019 Jul 29;24(15):2752. doi: 10.3390/molecules24152752.
5
Comparison of the Human A Adenosine Receptor Recognition by Adenosine and Inosine: New Insight from Supervised Molecular Dynamics Simulations.腺苷和肌苷对人A1腺苷受体识别的比较:来自监督分子动力学模拟的新见解。
ChemMedChem. 2017 Aug 22;12(16):1319-1326. doi: 10.1002/cmdc.201700200. Epub 2017 Jun 30.
6
Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation.统计分析分子动力学模拟:提供激动剂依赖性 GPCR 激活的 P 值。
Sci Rep. 2020 Nov 17;10(1):19942. doi: 10.1038/s41598-020-77072-4.
7
Supporting the Identification of Novel Fragment-Based Positive Allosteric Modulators Using a Supervised Molecular Dynamics Approach: A Retrospective Analysis Considering the Human A2A Adenosine Receptor as a Key Example.使用监督分子动力学方法支持新型基于片段的正变构调节剂的鉴定:以人A2A腺苷受体为例的回顾性分析
Molecules. 2017 May 16;22(5):818. doi: 10.3390/molecules22050818.
8
Molecular dynamics simulations of the adenosine A2a receptor: structural stability, sampling, and convergence.腺苷 A2a 受体的分子动力学模拟:结构稳定性、采样和收敛。
J Chem Inf Model. 2013 May 24;53(5):1168-78. doi: 10.1021/ci300610w. Epub 2013 Apr 25.
9
Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations.使用监督分子动力学(SuMD)模拟解析配体-蛋白质识别途径的复杂性
J Chem Inf Model. 2016 Apr 25;56(4):687-705. doi: 10.1021/acs.jcim.5b00702. Epub 2016 Apr 14.
10
Ensemble Docking in Drug Discovery: How Many Protein Configurations from Molecular Dynamics Simulations are Needed To Reproduce Known Ligand Binding?药物发现中的整体对接:从分子动力学模拟中需要多少种蛋白质构象来重现已知的配体结合?
J Phys Chem B. 2019 Jun 27;123(25):5189-5195. doi: 10.1021/acs.jpcb.8b11491. Epub 2019 Feb 12.

引用本文的文献

1
A Computational Perspective to Intermolecular Interactions and the Role of the Solvent on Regulating Protein Properties.分子间相互作用的计算视角以及溶剂在调节蛋白质性质中的作用
Chem Rev. 2025 Aug 13;125(15):7023-7056. doi: 10.1021/acs.chemrev.4c00807. Epub 2025 Jul 28.
2
Integrating Hydrogen Exchange with Molecular Dynamics for Improved Ligand Binding Predictions.将氢交换与分子动力学相结合以改进配体结合预测
J Chem Inf Model. 2025 Jun 23;65(12):6144-6154. doi: 10.1021/acs.jcim.5c00397. Epub 2025 Jun 11.
3
Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD).
通过多步行者监督分子动力学(mwSuMD)解决的隐藏GPCR结构转变。
Elife. 2025 Apr 30;13:RP96513. doi: 10.7554/eLife.96513.
4
Thermal Titration Molecular Dynamics: The Revenge of the Fragments.热滴定分子动力学:片段的反击
J Chem Inf Model. 2025 Feb 10;65(3):1492-1513. doi: 10.1021/acs.jcim.4c01681. Epub 2025 Jan 21.
5
Potent and Selective Human 5-HT Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic Serendipity.强效且选择性的人5-羟色胺(5-HT)血清素受体拮抗剂:合成偶然发现的4'-氰基-(N)-甲碳环腺苷类似物。
J Med Chem. 2024 Dec 12;67(23):21264-21291. doi: 10.1021/acs.jmedchem.4c02174. Epub 2024 Nov 26.
6
Computer-aided Drug Discovery Approaches in the Identification of Anticancer Drugs from Natural Products: A Review.从天然产物中鉴定抗癌药物的计算机辅助药物发现方法:综述
Curr Comput Aided Drug Des. 2025;21(1):1-14. doi: 10.2174/0115734099283410240406064042.
7
Structure of METTL3-METTL14 with an m6A nucleotide reveals insights into m6A conversion and sensing.含N6-甲基腺苷核苷酸的METTL3-METTL14结构揭示了对N6-甲基腺苷转化和识别的见解。
Res Sq. 2024 Oct 23:rs.3.rs-3150186. doi: 10.21203/rs.3.rs-3150186/v1.
8
"Dual Anta-Inhibitors" of the A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies.A腺苷受体与酪蛋白激酶CK1δ的“双拮抗剂”:合成、生物学评价及分子模拟研究
Pharmaceuticals (Basel). 2023 Jan 23;16(2):167. doi: 10.3390/ph16020167.
9
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.海洋天然产物的结构修饰激发了具有抗肿瘤活性的新型 3-氨基-1,2,4-三嗪 PDK 抑制剂文库在胰腺导管腺癌中的应用。
Mar Drugs. 2023 May 4;21(5):288. doi: 10.3390/md21050288.
10
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies.计算机辅助药物设计方法的过去、现在和未来展望。
Molecules. 2023 May 5;28(9):3906. doi: 10.3390/molecules28093906.